Iodamide

CHEMBL1201239 Phase 4 Aprobado Small molecule
Half-Life
Bioavailability
Protein Binding
Molecular Weight
627.9 g/mol
LogP
1.7
Phase
4

This iodine-containing contrast agent was used to make blood vessels and body cavities visible on X-ray imaging studies. Like other iodinated contrast media, it works by absorbing X-rays more strongly than surrounding tissues, creating visible contrast on radiographic images.

Peso molecular

627,9400 g/mol

LogP

1,70

TPSA

95,50 Ų

Regla de cinco de Lipinski

Cumple

Mecanismo de acción

Enhances the contrast of specific tissues or structures during medical imaging procedures by altering the local signal intensity or X-ray absorption characteristics.

Pharmacokinetics (PK)

Pharmacodynamics (PD)

Mecanismo

Enhances the contrast of specific tissues or structures during medical imaging procedures by altering the local signal intensity or X-ray absorption characteristics.

Estructura 2D

SVG PNG

Cite this structure


                        

Embed this structure


                        

SMILES

CC(=O)NCc1c(I)c(NC(C)=O)c(I)c(C(=O)O)c1I

InChI

InChI=1S/C12H11I3N2O4/c1-4(18)16-3-6-8(13)7(12(20)21)10(15)11(9(6)14)17-5(2)19/h3H2,1-2H3,(H,16,18)(H,17,19)(H,20,21)

Molecular Formula

C12H11I3N2O4

HBD / HBA

3 / 4

Enlaces Rotables

4

Átomos Pesados

21

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

Preguntas frecuentes

This iodine-containing contrast agent was used to make blood vessels and body cavities visible on X-ray imaging studies. Like other iodinated contrast media, it works by absorbing X-rays more strongly than surrounding tissues, creating visible contrast on radiographic images.

Enhances the contrast of specific tissues or structures during medical imaging procedures by altering the local signal intensity or X-ray absorption characteristics.

Yes, Iodamide is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

  • ChEMBL — European Bioinformatics Institute (EBI). CHEMBL1201239. Open-access bioactivity database.
  • PubChem — National Center for Biotechnology Information (NCBI). CID 3723. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-04.

Aviso médico

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.